Humacyte Inc
NASDAQ:HUMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Humacyte Inc
NASDAQ:HUMA
|
US |
|
G
|
Grenergy Renovables SA
F:5GR
|
ES |
|
Logista Integral SA
MAD:LOG
|
ES |
|
Sibanye Stillwater Ltd
F:47VS
|
ZA |
|
Columbia Sportswear Co
NASDAQ:COLM
|
US |
|
Agora Inc
NASDAQ:API
|
US |
|
Ebusco Holding NV
AEX:EBUS
|
NL |
|
H
|
Hang Lung Group Ltd
XMUN:HLU
|
HK |
|
T
|
Thai Metal Drum Manufacturing PCL
SET:TMD
|
TH |
|
R
|
Royal Gold Inc
XMUN:RG3
|
US |
|
A
|
Air China Ltd
XMUN:AD2
|
CN |
Intrinsic Value
Is HUMA undervalued or overvalued?
See the intrinsic value estimate for Humacyte Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
HUMA looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with HUMA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Humacyte Does
Humacyte develops and manufactures bioengineered human tissue for use in surgery and trauma care. Its main product is a laboratory-grown vessel made from human cells that can be used to replace or repair damaged blood vessels. The company is focused on giving doctors an off-the-shelf tissue option where the body needs a strong, living conduit rather than a synthetic tube.
- Headquarters
- United States of America US
- Employees
- 184
- IPO date
- Sep 22, 2020
Earnings Waterfall
Humacyte Inc
The intrinsic value for Humacyte Inc (HUMA) under the Base Case is hidden USD.
Compared with the current market price of 0.41295 USD, the stock appears hidden.